Albert David Limited (NSE:ALBERTDAVD)

Market Cap	4.30B -34.5%
Revenue (ttm)	3.23B -10.4%
Net Income	96.12M -76.2%
EPS	16.84 -76.2%
Shares Out	n/a
PE Ratio	44.77
Forward PE	n/a
Dividend	5.00 (0.68%)
Ex-Dividend Date	Jul 25, 2025

Volume	994
Average Volume	3,431
Open	735.30
Previous Close	735.30
Day's Range	732.35 - 740.10
52-Week Range	663.35 - 957.50
Beta	-0.06
RSI	57.78
Earnings Date	Feb 11, 2026

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1938
• Employees: 1,805
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALBERTDAVD

Financial Performance

In fiscal year 2025, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.